Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-03-28

Pages: 152 Pages

Report ld: 4669728

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spine Biologics Market Size(US$)

CAGR 2025-2031

3.3%

Market Size,2031

USD 3,153

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 2,595 million

Market Forecast in 2031(Value)

US$ 3,153 million

CAGR

3.3%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Spine Biologics was estimated to be worth US$ 2520 million and is forecast to reach approximately US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.

Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%.

North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%.

In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Spine Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spine Biologics.

The Spine Biologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spine Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Spine Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company

Medtronic

Depuy Synthes

Stryker Corporation

Nuvasive

Zimmer Biomet

Orthofix International

Globus Medical

alphatec spine

K2M

Exactech

Wright Medical Technology

X-Spine

Nutech

Arthrex

Segment by Type

Bone Graft

Bone Graft Substitute

Platelet Rich Plasma (PRP)

BMAC (Bone Marrow Aspirate Concentrate)

Segment by Application

Anterior Cervical Discectomy and Fusion

Posterior Lumbar Interbody Fusion

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Spine Biologics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Spine Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spine Biologics sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Spine Biologics Product Introduction

1.2 Market by Type

1.2.1 Global Spine Biologics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Bone Graft

1.2.3 Bone Graft Substitute

1.2.4 Platelet Rich Plasma (PRP)

1.2.5 BMAC (Bone Marrow Aspirate Concentrate)

1.3 Market by Application

1.3.1 Global Spine Biologics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Anterior Cervical Discectomy and Fusion

1.3.3 Posterior Lumbar Interbody Fusion

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Spine Biologics Market Size Estimates and Forecasts

2.1.1 Global Spine Biologics Revenue 2020-2031

2.1.2 Global Spine Biologics Sales 2020-2031

2.2 Spine Biologics Market Size by Region: 2024 Versus 2031

2.3 Spine Biologics Sales by Region (2020-2031)

2.3.1 Global Spine Biologics Sales by Region: 2020-2025

2.3.2 Global Spine Biologics Sales Forecast by Region (2026-2031)

2.3.3 Global Spine Biologics Sales Market Share by Region (2020-2031)

2.4 Spine Biologics Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Spine Biologics Revenue by Region: 2020-2025

2.4.2 Global Spine Biologics Revenue Forecast by Region (2026-2031)

2.4.3 Global Spine Biologics Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Spine Biologics Sales by Type (2020-2031)

3.1.1.1 Global Spine Biologics Sales Volume by Type (2020-2031)

3.1.1.2 Global Spine Biologics Sales Market Share by Type (2020-2031)

3.1.2 Global Spine Biologics Revenue by Type (2020-2031)

3.1.2.1 Global Spine Biologics Revenue by Type (2020-2031)

3.1.2.2 Global Spine Biologics Revenue Market Share by Type (2020-2031)

3.1.3 Spine Biologics Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Spine Biologics Sales by Application (2020-2031)

3.2.1.1 Global Spine Biologics Sales Volume by Application (2020-2031)

3.2.1.2 Global Spine Biologics Sales Market Share by Application (2020-2031)

3.2.2 Global Spine Biologics Revenue by Application (2020-2031)

3.2.2.1 Global Spine Biologics Revenue by Application (2020-2031)

3.2.2.2 Global Spine Biologics Revenue Market Share by Application (2020-2031)

3.2.3 Spine Biologics Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Bone Graft of Spine Biologics Revenue Market Share by Application

3.3.2 Bone Graft Substitute of Spine Biologics Revenue Market Share by Application

3.3.3 Platelet Rich Plasma (PRP) of Spine Biologics Revenue Market Share by Application

3.3.4 BMAC (Bone Marrow Aspirate Concentrate) of Spine Biologics Revenue Market Share by Application

4 Global Spine Biologics by Manufacturers

4.1 Global Top Spine Biologics Manufacturers by Sales (2020-2025)

4.1.1 Global Spine Biologics Sales by Manufacturer (2020-2025)

4.1.2 Global Spine Biologics Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Spine Biologics Manufacturers by Revenue (2020-2025)

4.2.1 Global Spine Biologics Revenue by Manufacturer (2020-2025)

4.2.2 Global Spine Biologics Revenue Share by Manufacturer (2020-2025)

4.3 Global Spine Biologics Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Spine Biologics Manufacturers Covered: Ranking by Revenue

4.4.2 Global Spine Biologics Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Spine Biologics Manufacturing Base Distribution, Product Type

4.5.1 Spine Biologics Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Spine Biologics Market

4.5.3 Manufacturers Spine Biologics Product Type and Application

4.5.4 Bone Graft Market Sales of Spine Biologics by Manufacturer

4.5.5 Bone Graft Substitute Market Sales of Spine Biologics by Manufacturer

4.5.6 Platelet Rich Plasma (PRP) Market Sales of Spine Biologics by Manufacturer

4.5.7 BMAC (Bone Marrow Aspirate Concentrate) Market Sales of Spine Biologics by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Medtronic

5.1.1 Medtronic Company Information

5.1.2 Medtronic Description, Business Overview

5.1.3 Medtronic Spine Biologics Products Offered

5.1.4 Medtronic Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Medtronic Spine Biologics Sales by Product in 2024

5.1.6 Medtronic Spine Biologics Sales by Application in 2024

5.1.7 Medtronic Spine Biologics Sales by Geographic Area in 2024

5.1.8 Medtronic Recent Developments

5.2 Depuy Synthes

5.2.1 Depuy Synthes Company Information

5.2.2 Depuy Synthes Description, Business Overview

5.2.3 Depuy Synthes Spine Biologics Products Offered

5.2.4 Depuy Synthes Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Depuy Synthes Spine Biologics Sales by Product in 2024

5.2.6 Depuy Synthes Spine Biologics Sales by Application in 2024

5.2.7 Depuy Synthes Spine Biologics Sales by Geographic Area in 2024

5.2.8 Depuy Synthes Recent Developments

5.3 Stryker Corporation

5.3.1 Stryker Corporation Company Information

5.3.2 Stryker Corporation Description, Business Overview

5.3.3 Stryker Corporation Spine Biologics Products Offered

5.3.4 Stryker Corporation Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Stryker Corporation Spine Biologics Sales by Product in 2024

5.3.6 Stryker Corporation Spine Biologics Sales by Application in 2024

5.3.7 Stryker Corporation Spine Biologics Sales by Geographic Area in 2024

5.3.8 Stryker Corporation Recent Developments

5.4 Nuvasive

5.4.1 Nuvasive Company Information

5.4.2 Nuvasive Description, Business Overview

5.4.3 Nuvasive Spine Biologics Products Offered

5.4.4 Nuvasive Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Nuvasive Spine Biologics Sales by Product in 2024

5.4.6 Nuvasive Spine Biologics Sales by Application in 2024

5.4.7 Nuvasive Spine Biologics Sales by Geographic Area in 2024

5.4.8 Nuvasive Recent Developments

5.5 Zimmer Biomet

5.5.1 Zimmer Biomet Company Information

5.5.2 Zimmer Biomet Description, Business Overview

5.5.3 Zimmer Biomet Spine Biologics Products Offered

5.5.4 Zimmer Biomet Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.5.5 Zimmer Biomet Spine Biologics Sales by Product in 2024

5.5.6 Zimmer Biomet Spine Biologics Sales by Application in 2024

5.5.7 Zimmer Biomet Spine Biologics Sales by Geographic Area in 2024

5.5.8 Zimmer Biomet Recent Developments

5.6 Orthofix International

5.6.1 Orthofix International Company Information

5.6.2 Orthofix International Description, Business Overview

5.6.3 Orthofix International Spine Biologics Products Offered

5.6.4 Orthofix International Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Orthofix International Spine Biologics Sales by Product in 2024

5.6.6 Orthofix International Spine Biologics Sales by Application in 2024

5.6.7 Orthofix International Spine Biologics Sales by Geographic Area in 2024

5.6.8 Orthofix International Recent Developments

5.7 Globus Medical

5.7.1 Globus Medical Company Information

5.7.2 Globus Medical Description, Business Overview

5.7.3 Globus Medical Spine Biologics Products Offered

5.7.4 Globus Medical Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Globus Medical Spine Biologics Sales by Product in 2024

5.7.6 Globus Medical Spine Biologics Sales by Application in 2024

5.7.7 Globus Medical Spine Biologics Sales by Geographic Area in 2024

5.7.8 Globus Medical Recent Developments

5.8 alphatec spine

5.8.1 alphatec spine Company Information

5.8.2 alphatec spine Description, Business Overview

5.8.3 alphatec spine Spine Biologics Products Offered

5.8.4 alphatec spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.8.5 alphatec spine Spine Biologics Sales by Product in 2024

5.8.6 alphatec spine Spine Biologics Sales by Application in 2024

5.8.7 alphatec spine Spine Biologics Sales by Geographic Area in 2024

5.8.8 alphatec spine Recent Developments

5.9 K2M

5.9.1 K2M Company Information

5.9.2 K2M Description, Business Overview

5.9.3 K2M Spine Biologics Products Offered

5.9.4 K2M Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.9.5 K2M Spine Biologics Sales by Product in 2024

5.9.6 K2M Spine Biologics Sales by Application in 2024

5.9.7 K2M Spine Biologics Sales by Geographic Area in 2024

5.9.8 K2M Recent Developments

5.10 Exactech

5.10.1 Exactech Company Information

5.10.2 Exactech Description, Business Overview

5.10.3 Exactech Spine Biologics Products Offered

5.10.4 Exactech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.10.5 Exactech Spine Biologics Sales by Product in 2024

5.10.6 Exactech Spine Biologics Sales by Application in 2024

5.10.7 Exactech Spine Biologics Sales by Geographic Area in 2024

5.10.8 Exactech Recent Developments

5.11 Wright Medical Technology

5.11.1 Wright Medical Technology Company Information

5.11.2 Wright Medical Technology Description, Business Overview

5.11.3 Wright Medical Technology Spine Biologics Products Offered

5.11.4 Wright Medical Technology Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.11.5 Wright Medical Technology Spine Biologics Sales by Product in 2024

5.11.6 Wright Medical Technology Spine Biologics Sales by Application in 2024

5.11.7 Wright Medical Technology Spine Biologics Sales by Geographic Area in 2024

5.11.8 Wright Medical Technology Recent Developments

5.12 X-Spine

5.12.1 X-Spine Company Information

5.12.2 X-Spine Description, Business Overview

5.12.3 X-Spine Spine Biologics Products Offered

5.12.4 X-Spine Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.12.5 X-Spine Spine Biologics Sales by Product in 2024

5.12.6 X-Spine Spine Biologics Sales by Application in 2024

5.12.7 X-Spine Spine Biologics Sales by Geographic Area in 2024

5.12.8 X-Spine Recent Developments

5.13 Nutech

5.13.1 Nutech Company Information

5.13.2 Nutech Description, Business Overview

5.13.3 Nutech Spine Biologics Products Offered

5.13.4 Nutech Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.13.5 Nutech Spine Biologics Sales by Product in 2024

5.13.6 Nutech Spine Biologics Sales by Application in 2024

5.13.7 Nutech Spine Biologics Sales by Geographic Area in 2024

5.13.8 Nutech Recent Developments

5.14 Arthrex

5.14.1 Arthrex Company Information

5.14.2 Arthrex Description, Business Overview

5.14.3 Arthrex Spine Biologics Products Offered

5.14.4 Arthrex Spine Biologics Sales, Revenue and Gross Margin (2020-2025)

5.14.5 Arthrex Spine Biologics Sales by Product in 2024

5.14.6 Arthrex Spine Biologics Sales by Application in 2024

5.14.7 Arthrex Spine Biologics Sales by Geographic Area in 2024

5.14.8 Arthrex Recent Developments

6 North America

6.1 North America Spine Biologics Market Size YoY Growth 2020-2031

6.2 North America Spine Biologics Market Facts & Figures by Country

6.2.1 North America Spine Biologics Sales by Country (2020-2031)

6.2.2 North America Spine Biologics Revenue by Country (2020-2031)

6.3 North America Spine Biologics Sales by Type (2020-2025)

6.4 North America Spine Biologics Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Spine Biologics Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Spine Biologics Market Facts & Figures by Region

7.2.1 Asia-Pacific Spine Biologics Sales by Region (2020-2031)

7.2.2 Asia-Pacific Spine Biologics Revenue by Region (2020-2031)

7.3 Asia-Pacific Spine Biologics Sales by Type (2020-2025)

7.4 Asia-Pacific Spine Biologics Sales by Application (2020-2025)

8 Europe

8.1 Europe Spine Biologics Market Size YoY Growth 2020-2031

8.2 Europe Spine Biologics Market Facts & Figures by Country

8.2.1 Europe Spine Biologics Sales by Country (2020-2031)

8.2.2 Europe Spine Biologics Revenue by Country (2020-2031)

8.3 Europe Spine Biologics Sales by Type (2020-2025)

8.4 Europe Spine Biologics Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Spine Biologics Market Size YoY Growth 2020-2031

9.2 Latin America Spine Biologics Market Facts & Figures by Country

9.2.1 Latin America Spine Biologics Sales by Country (2020-2031)

9.2.2 Latin America Spine Biologics Revenue by Country (2020-2031)

9.3 Latin America Spine Biologics Sales by Type (2020-2025)

9.4 Latin America Spine Biologics Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Spine Biologics Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Spine Biologics Market Facts & Figures by Country

10.2.1 Middle East and Africa Spine Biologics Sales by Country (2020-2031)

10.2.2 Middle East and Africa Spine Biologics Revenue by Country (2020-2031)

10.3 Middle East and Africa Spine Biologics Sales by Type (2020-2025)

10.4 Middle East and Africa Spine Biologics Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Spine Biologics Supply Chain Analysis

11.2 Spine Biologics Key Raw Materials and Upstream Suppliers

11.3 Spine Biologics Clients Analysis

11.4 Spine Biologics Sales Channel and Sales Model Analysis

11.4.1 Spine Biologics Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Spine Biologics Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Spine Biologics Distributors

12 Spine Biologics Market Dynamics

12.1 Spine Biologics Industry Trends

12.2 Spine Biologics Market Drivers

12.3 Spine Biologics Market Challenges

12.4 Spine Biologics Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Spine Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Spine Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Spine Biologics Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Spine Biologics Sales by Region (2020-2025) & (K Units)

Table 5. Global Spine Biologics Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Spine Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Spine Biologics Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Spine Biologics Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Spine Biologics Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Spine Biologics Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Spine Biologics Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Spine Biologics Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Spine Biologics Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Spine Biologics Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Spine Biologics Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Spine Biologics Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Spine Biologics Sales Share by Manufacturer (2020-2025)

Table 18. Spine Biologics Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Spine Biologics Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Spine Biologics Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Spine Biologics Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Spine Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2024)

Table 24. Spine Biologics Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Spine Biologics Market

Table 26. Manufacturers Spine Biologics Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Medtronic Company Information

Table 29. Medtronic Description and Business Overview

Table 30. Medtronic Spine Biologics Product

Table 31. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Medtronic Sales Proportion of Spine Biologics by Product in 2024

Table 33. Medtronic Sales Proportion of Spine Biologics by Application in 2024

Table 34. Medtronic Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 35. Medtronic Recent Developments

Table 36. Depuy Synthes Company Information

Table 37. Depuy Synthes Description and Business Overview

Table 38. Depuy Synthes Spine Biologics Product

Table 39. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. Depuy Synthes Sales Proportion of Spine Biologics by Product in 2024

Table 41. Depuy Synthes Sales Proportion of Spine Biologics by Application in 2024

Table 42. Depuy Synthes Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 43. Depuy Synthes Recent Developments

Table 44. Stryker Corporation Company Information

Table 45. Stryker Corporation Description and Business Overview

Table 46. Stryker Corporation Spine Biologics Product

Table 47. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Stryker Corporation Sales Proportion of Spine Biologics by Product in 2024

Table 49. Stryker Corporation Sales Proportion of Spine Biologics by Application in 2024

Table 50. Stryker Corporation Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 51. Stryker Corporation Recent Developments

Table 52. Nuvasive Company Information

Table 53. Nuvasive Description and Business Overview

Table 54. Nuvasive Spine Biologics Product

Table 55. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Nuvasive Sales Proportion of Spine Biologics by Product in 2024

Table 57. Nuvasive Sales Proportion of Spine Biologics by Application in 2024

Table 58. Nuvasive Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 59. Nuvasive Recent Developments

Table 60. Zimmer Biomet Company Information

Table 61. Zimmer Biomet Description and Business Overview

Table 62. Zimmer Biomet Spine Biologics Product

Table 63. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Zimmer Biomet Sales Proportion of Spine Biologics by Product in 2024

Table 65. Zimmer Biomet Sales Proportion of Spine Biologics by Application in 2024

Table 66. Zimmer Biomet Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 67. Zimmer Biomet Recent Developments

Table 68. Orthofix International Company Information

Table 69. Orthofix International Description and Business Overview

Table 70. Orthofix International Spine Biologics Product

Table 71. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. Orthofix International Sales Proportion of Spine Biologics by Product in 2024

Table 73. Orthofix International Sales Proportion of Spine Biologics by Application in 2024

Table 74. Orthofix International Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 75. Orthofix International Recent Developments

Table 76. Globus Medical Company Information

Table 77. Globus Medical Description and Business Overview

Table 78. Globus Medical Spine Biologics Product

Table 79. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Globus Medical Sales Proportion of Spine Biologics by Product in 2024

Table 81. Globus Medical Sales Proportion of Spine Biologics by Application in 2024

Table 82. Globus Medical Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 83. Globus Medical Recent Developments

Table 84. alphatec spine Company Information

Table 85. alphatec spine Description and Business Overview

Table 86. alphatec spine Spine Biologics Product

Table 87. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. alphatec spine Sales Proportion of Spine Biologics by Product in 2024

Table 89. alphatec spine Sales Proportion of Spine Biologics by Application in 2024

Table 90. alphatec spine Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 91. alphatec spine Recent Developments

Table 92. K2M Company Information

Table 93. K2M Description and Business Overview

Table 94. K2M Spine Biologics Product

Table 95. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 96. K2M Sales Proportion of Spine Biologics by Product in 2024

Table 97. K2M Sales Proportion of Spine Biologics by Application in 2024

Table 98. K2M Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 99. K2M Recent Developments

Table 100. Exactech Company Information

Table 101. Exactech Description and Business Overview

Table 102. Exactech Spine Biologics Product

Table 103. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 104. Exactech Sales Proportion of Spine Biologics by Product in 2024

Table 105. Exactech Sales Proportion of Spine Biologics by Application in 2024

Table 106. Exactech Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 107. Exactech Recent Developments

Table 108. Wright Medical Technology Company Information

Table 109. Wright Medical Technology Description and Business Overview

Table 110. Wright Medical Technology Spine Biologics Product

Table 111. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 112. Wright Medical Technology Sales Proportion of Spine Biologics by Product in 2024

Table 113. Wright Medical Technology Sales Proportion of Spine Biologics by Application in 2024

Table 114. Wright Medical Technology Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 115. Wright Medical Technology Recent Developments

Table 116. X-Spine Company Information

Table 117. X-Spine Description and Business Overview

Table 118. X-Spine Spine Biologics Product

Table 119. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 120. X-Spine Sales Proportion of Spine Biologics by Product in 2024

Table 121. X-Spine Sales Proportion of Spine Biologics by Application in 2024

Table 122. X-Spine Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 123. X-Spine Recent Developments

Table 124. Nutech Company Information

Table 125. Nutech Description and Business Overview

Table 126. Nutech Spine Biologics Product

Table 127. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Nutech Sales Proportion of Spine Biologics by Product in 2024

Table 129. Nutech Sales Proportion of Spine Biologics by Application in 2024

Table 130. Nutech Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 131. Nutech Recent Developments

Table 132. Arthrex Company Information

Table 133. Arthrex Description and Business Overview

Table 134. Arthrex Spine Biologics Product

Table 135. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 136. Arthrex Sales Proportion of Spine Biologics by Product in 2024

Table 137. Arthrex Sales Proportion of Spine Biologics by Application in 2024

Table 138. Arthrex Sales Proportion of Spine Biologics by Geographic Area in 2024

Table 139. Arthrex Recent Developments

Table 140. North America Spine Biologics Sales by Country (2020-2025) & (K Units)

Table 141. North America Spine Biologics Sales by Country (2026-2031) & (K Units)

Table 142. North America Spine Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 143. North America Spine Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 144. North America Spine Biologics Sales by Type (2020-2025) & (K Units)

Table 145. North America Spine Biologics Sales by Application (2020-2025) & (K Units)

Table 146. Asia-Pacific Spine Biologics Sales by Region (2020-2025) & (K Units)

Table 147. Asia-Pacific Spine Biologics Sales by Region (2026-2031) & (K Units)

Table 148. Asia-Pacific Spine Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 149. Asia-Pacific Spine Biologics Revenue by Region (2026-2031) & (US$ Million)

Table 150. Asia-Pacific Spine Biologics Sales by Type (2020-2025) & (K Units)

Table 151. Asia-Pacific Spine Biologics Sales by Application (2020-2025) & (K Units)

Table 152. Europe Spine Biologics Sales by Country (2020-2025) & (K Units)

Table 153. Europe Spine Biologics Sales by Country (2026-2031) & (K Units)

Table 154. Europe Spine Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 155. Europe Spine Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 156. Europe Spine Biologics Sales by Type (2020-2025) & (K Units)

Table 157. Europe Spine Biologics Sales by Application (2020-2025) & (K Units)

Table 158. Latin America Spine Biologics Sales by Country (2020-2025) & (K Units)

Table 159. Latin America Spine Biologics Sales by Country (2026-2031) & (K Units)

Table 160. Latin America Spine Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 161. Latin America Spine Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 162. Latin America Spine Biologics Sales by Type (2020-2025) & (K Units)

Table 163. Latin America Spine Biologics Sales by Application (2020-2025) & (K Units)

Table 164. Middle East and Africa Spine Biologics Sales by Country (2020-2025) & (K Units)

Table 165. Middle East and Africa Spine Biologics Sales by Country (2026-2031) & (K Units)

Table 166. Middle East and Africa Spine Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 167. Middle East and Africa Spine Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 168. Middle East and Africa Spine Biologics Sales by Type (2020-2025) & (K Units)

Table 169. Middle East and Africa Spine Biologics Sales by Application (2020-2025) & (K Units)

Table 170. Spine Biologics Key Raw Materials, Industry Status and Trend

Table 171. Spine Biologics Key Raw Materials and Upstream Suppliers

Table 172. Spine Biologics Clients Status and Trend

Table 173. Spine Biologics Typical Clients

Table 174. Spine Biologics Distributors

Table 175. Spine Biologics Market Trends

Table 176. Spine Biologics Market Drivers

Table 177. Spine Biologics Market Challenges

Table 178. Spine Biologics Market Restraints

Table 179. Research Programs/Design for This Report

Table 180. Key Data Information from Secondary Sources

Table 181. Key Data Information from Primary Sources

Table 182. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Spine Biologics Product Picture

Figure 2. Global Spine Biologics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Spine Biologics Sales Market Share by Type in 2024 & 2031

Figure 4. Bone Graft Product Picture

Figure 5. Bone Graft Substitute Product Picture

Figure 6. Platelet Rich Plasma (PRP) Product Picture

Figure 7. BMAC (Bone Marrow Aspirate Concentrate) Product Picture

Figure 8. Global Spine Biologics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Spine Biologics Sales Market Share by Application in 2024 & 2031

Figure 10. Anterior Cervical Discectomy and Fusion

Figure 11. Posterior Lumbar Interbody Fusion

Figure 12. Others

Figure 13. Spine Biologics Report Years Considered

Figure 14. Global Spine Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Spine Biologics Market Size 2020-2031 (US$ Million)

Figure 16. Global Spine Biologics Sales 2020-2031 (K Units)

Figure 17. Global Spine Biologics Sales Market Share Forecast by Region (2020-2031)

Figure 18. Global Spine Biologics Revenue Market Share by Region (2020-2031)

Figure 19. Global Spine Biologics Sales Market Share Forecast by Type (2020-2031)

Figure 20. Global Spine Biologics Revenue Market Share Forecast by Type (2020-2031)

Figure 21. Spine Biologics Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 22. Global Spine Biologics Sales Market Share Forecast by Application (2020-2031)

Figure 23. Global Spine Biologics Revenue Market Share Forecast by Application (2020-2031)

Figure 24. Spine Biologics Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 25. Bone Graft of Spine Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 26. Bone Graft Substitute of Spine Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 27. Platelet Rich Plasma (PRP) of Spine Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 28. BMAC (Bone Marrow Aspirate Concentrate) of Spine Biologics Revenue Market Share by Application, 2024 VS 2031

Figure 29. Global Spine Biologics Sales Share by Manufacturer in 2024

Figure 30. Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 31. Bone Graft Market Sales Proportion by Manufacturer in 2024

Figure 32. Bone Graft Substitute Market Sales Proportion by Manufacturer in 2024

Figure 33. Platelet Rich Plasma (PRP) Market Sales Proportion by Manufacturer in 2024

Figure 34. BMAC (Bone Marrow Aspirate Concentrate) Market Sales Proportion by Manufacturer in 2024

Figure 35. North America Spine Biologics Revenue 2020-2031 (US$ Million)

Figure 36. North America Spine Biologics Sales Market Share by Type (2020-2025)

Figure 37. North America Spine Biologics Sales Market Share by Application (2020-2025)

Figure 38. Asia-Pacific Spine Biologics Revenue 2020-2031 (US$ Million)

Figure 39. Asia-Pacific Spine Biologics Sales Market Share by Region (2020-2031)

Figure 40. Asia-Pacific Spine Biologics Revenue Market Share by Region (2020-2031)

Figure 41. Asia-Pacific Spine Biologics Sales Market Share by Type (2020-2025)

Figure 42. Asia-Pacific Spine Biologics Sales Market Share by Application (2020-2025)

Figure 43. Europe Spine Biologics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 44. Europe Spine Biologics Sales Market Share by Country (2020-2031)

Figure 45. Europe Spine Biologics Revenue Market Share by Country (2020-2031)

Figure 46. Europe Spine Biologics Sales Market Share by Type (2020-2025)

Figure 47. Europe Spine Biologics Sales Market Share by Application (2020-2025)

Figure 48. Latin America Spine Biologics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 49. Latin America Spine Biologics Sales Market Share by Country (2020-2031)

Figure 50. Latin America Spine Biologics Revenue Market Share by Country (2020-2025)

Figure 51. Latin America Spine Biologics Sales Market Share by Type (2020-2025)

Figure 52. Latin America Spine Biologics Sales Market Share by Application (2020-2025)

Figure 53. Middle East and Africa Spine Biologics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 54. Middle East and Africa Spine Biologics Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Spine Biologics Revenue Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Spine Biologics Sales Market Share by Type (2020-2025)

Figure 57. Middle East and Africa Spine Biologics Sales Market Share by Application (2020-2025)

Figure 58. Spine Biologics Supply Chain (Upstream and Downstream Market)

Figure 59. Global Production Market Share of Spine Biologics Raw Materials by Region in 2024

Figure 60. Spine Biologics Distribution Channels

Figure 61. Global Spine Biologics Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 62. Global Spine Biologics Percentage 2020-2031: Online Sales VS Offline Sales

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Spine Biologics in 2031? zhanKai

The global market size of Spine Biologics in 2031 was 3153 Million USD.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Spine Biologics market? shouQi

What is the annual compound growth rate of the global Spine Biologics market size from 2025 to 2031? shouQi

What was the global market size of Spine Biologics in 2025? shouQi

Related Reports

Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-11
Pages: 169
USD 4900.00
(Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-07-11
Pages: 137
USD 4250.00
(Single User License)
Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 121
USD 2900.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-11
Pages: 142
USD 3950.00
(Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 164
USD 4900.00
(Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 97
USD 4250.00
(Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 121
USD 3950.00
(Single User License)
Global Spine Biologics Market Research Report 2025
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-17
Pages: 161
USD 5600.00
(Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published Date: 2024-04-16
Pages: 150
USD 5900.00
(Single User License)

Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spine Biologics market is projected to grow from US$ 2595 million in 2025 to US$ 3864 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-11
Pages: 169
USD 4900.00 (Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spine Biologics market size was US$ 2595 million in 2025 and is forecast to reach a readjusted size of US$ 3864 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-07-11
Pages: 137
USD 4250.00 (Single User License)
Global Spine Biologics Market Research Report 2026
The global Spine Biologics market was valued at US$ 2595 million in 2025 and is anticipated to reach US$ 3864 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 121
USD 2900.00 (Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spine Biologics was estimated to be worth US$ 2595 million in 2025 and is projected to reach US$ 3864 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-11
Pages: 142
USD 3950.00 (Single User License)
Global Spine Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Spine Biologics market is projected to grow from US$ 2520 million in 2024 to US$ 3153 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 164
USD 4900.00 (Single User License)
Global Spine Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Spine Biologics market size was US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 97
USD 4250.00 (Single User License)
Spine Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Spine Biologics was estimated to be worth US$ 2520 million in 2024 and is forecast to a readjusted size of US$ 3153 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 121
USD 3950.00 (Single User License)
Global Spine Biologics Market Research Report 2025
The global market for Spine Biologics was valued at US$ 2520 million in the year 2024 and is projected to reach a revised size of US$ 3153 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-01-16
Pages: 91
USD 2900.00 (Single User License)
Global Spine Biologics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-17
Pages: 161
USD 5600.00 (Single User License)
Global Spine Biologics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
Published: 2024-04-16
Pages: 150
USD 5900.00 (Single User License)